
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Premas is developing transformational technologies and partnering with pharmaceutical companies around the world to expedite their drug discovery programs by cutting down significantly both on costs & time to clinics. Axtex-4D, a three-dimensional cell culture platform, engineered to produce high-throughput screens for targeted immuno-oncology drug candidates, is compelling scientists to relook at their tumor-targeting strategies. The ex-vivo culture systematically mirrors the in-vivo tumor microenvironment and is poised to revolutionize both drug discovery & combinatorial therapies. D-Crypt, a platform for difficult-to-express proteins, is designed to considerably reduce time, cost, and risks associated with producing high-quality recombinant proteins. D-Crypt combines a yeast...
Protein supplies,difficult to express proteins,membrane proteins,recombinant vaccine development,vaccine pd & dsp,agribiotech: protein for regulatory submission,process development for preclinical lots and clinical trials,and gene-to-preclinical product
Premas biotech operates in the Biotechnology research industry.
Premas biotech's revenue is 11m - 100m
Premas biotech has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.